Double maintains 2 strategies that include NVAX - Novavax, Inc.
Current Value
$6.411 Year Return
Current Value
$6.411 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FHI | <0.01% | $3.32B | +16.46% | 3.05% |
L | -0.02% | $19.56B | +18.62% | 0.27% |
FWRD | 0.03% | $610.79M | -30.56% | 0.00% |
JOYY | 0.03% | $1.50B | +31.76% | 0.00% |
PKE | -0.04% | $267.99M | -16.30% | 3.73% |
GIS | 0.04% | $32.74B | -14.74% | 3.99% |
IMMP | -0.04% | $256.18M | -28.16% | 0.00% |
BXSL | -0.06% | - | - | 9.48% |
UUUU | 0.07% | $784.20M | -42.88% | 0.00% |
SBGI | -0.09% | $1.06B | +25.33% | 6.33% |
CLX | -0.10% | $18.14B | -2.90% | 3.29% |
RELY | 0.11% | $4.17B | +1.46% | 0.00% |
EXEL | 0.12% | $10.33B | +55.91% | 0.00% |
ALAR | -0.13% | $43.34M | -71.08% | 0.00% |
VIRT | 0.14% | $3.30B | +81.18% | 2.53% |
CSGS | -0.14% | $1.74B | +18.22% | 2.02% |
BRDG | 0.15% | $428.25M | +43.63% | 4.82% |
SBS | 0.15% | $12.21B | +10.22% | 0.00% |
ACGL | -0.16% | $36.14B | +9.57% | 0.00% |
FRT | 0.17% | $8.38B | -2.90% | 3.39% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FAT | -32.04% | $51.24M | -30.80% | 15.05% |
COLL | -30.23% | $939.84M | -23.23% | 0.00% |
MGNX | -23.96% | $80.12M | -90.94% | 0.00% |
FROG | -23.48% | $3.61B | -27.78% | 0.00% |
AVD | -20.41% | $126.67M | -65.63% | 0.68% |
SVV | -19.37% | $1.10B | -64.29% | 0.00% |
SLF | -19.27% | $32.80B | +6.12% | 4.15% |
FATBB | -18.29% | $48.04M | -31.13% | 15.56% |
OKLO | -17.70% | $3.01B | +77.59% | 0.00% |
KEP | -16.50% | $9.51B | -9.52% | 0.00% |
MSDL | -16.14% | $1.77B | -6.49% | 10.02% |
GLP | -15.71% | $1.81B | +18.07% | 5.43% |
IMNN | -15.02% | $15.35M | -45.60% | 0.00% |
BSM | -13.64% | $3.22B | -5.10% | 9.80% |
FLUX | -13.09% | $28.69M | -60.46% | 0.00% |
DOUG | -13.05% | $152.63M | +20.28% | 0.00% |
IIIV | -12.83% | $577.98M | +9.40% | 0.00% |
CME | -12.41% | $95.61B | +25.13% | 3.98% |
SRG | -11.96% | $181.75M | -66.39% | 0.00% |
NXE | -11.82% | $2.56B | -46.74% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ITOS | 53.17% | $228.02M | -55.25% | 0.00% |
GEN | 50.99% | $16.36B | +18.96% | 1.89% |
CDNA | 45.89% | $983.81M | +72.00% | 0.00% |
MTD | 45.10% | $24.61B | -11.95% | 0.00% |
SG | 39.49% | $2.93B | -1.34% | 0.00% |
ADMA | 38.55% | $4.71B | +203.36% | 0.00% |
GRPN | 36.41% | $747.25M | +47.68% | 0.00% |
ORGO | 33.24% | $547.90M | +54.29% | 0.00% |
IAS | 32.94% | $1.32B | -16.99% | 0.00% |
DOCN | 32.63% | $3.07B | -12.52% | 0.00% |
AMC | 32.42% | $1.24B | -8.60% | 0.00% |
NNI | 32.20% | $4.03B | +18.55% | 1.02% |
BLFS | 31.37% | $1.07B | +27.60% | 0.00% |
UI | 30.91% | $18.76B | +169.36% | 0.77% |
GH | 30.47% | $5.26B | +110.37% | 0.00% |
OUST | 29.71% | $482.82M | -8.92% | 0.00% |
ARCT | 29.68% | $287.20M | -67.99% | 0.00% |
INSG | 29.23% | $122.60M | +193.88% | 0.00% |
ACIU | 28.83% | $185.02M | -31.50% | 0.00% |
BNTX | 28.67% | $21.85B | -2.21% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -13.31% | $404.97M | 1.43% |
VIXY | -11.76% | $195.31M | 0.85% |
TFLO | -10.61% | $6.78B | 0.15% |
UGA | -10.40% | $88.11M | 0.97% |
TAIL | -9.73% | $86.92M | 0.59% |
BNO | -8.68% | $95.40M | 1% |
IBDQ | -8.47% | $3.18B | 0.1% |
USO | -8.32% | $1.02B | 0.6% |
DBE | -8.22% | $54.58M | 0.77% |
OILK | -7.86% | $66.42M | 0.69% |
USCI | -7.41% | $236.09M | 1.07% |
USL | -7.29% | $46.60M | 0.85% |
DBO | -7.11% | $197.54M | 0.77% |
UUP | -6.97% | $327.80M | 0.77% |
USDU | -6.60% | $213.46M | 0.5% |
ULST | -5.60% | $587.03M | 0.2% |
KRBN | -5.25% | $173.49M | 0.85% |
BIL | -5.12% | $41.08B | 0.1356% |
COMT | -4.56% | $674.22M | 0.48% |
GSG | -4.25% | $1.04B | 0.75% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FENY | -0.02% | $1.55B | 0.084% |
XONE | -0.05% | $628.76M | 0.03% |
VDE | 0.06% | $7.77B | 0.09% |
SHM | 0.09% | $3.41B | 0.2% |
XLE | -0.09% | $32.78B | 0.09% |
VNM | 0.14% | $416.76M | 0.7% |
FCG | -0.23% | $394.39M | 0.6% |
FXY | -0.26% | $546.19M | 0.4% |
XMPT | 0.26% | $172.81M | 1.98% |
IYE | 0.30% | $1.30B | 0.39% |
FTGC | 0.32% | $2.50B | 1.02% |
SHV | 0.40% | $20.11B | 0.15% |
URA | -0.42% | $2.68B | 0.69% |
DRLL | -0.60% | $299.17M | 0.41% |
XOP | -0.66% | $2.23B | 0.35% |
CARY | -0.72% | $347.36M | 0.8% |
RSPG | 0.74% | $507.19M | 0.4% |
USFR | -0.77% | $18.41B | 0.15% |
KCCA | -0.83% | $109.47M | 0.87% |
DBC | -0.86% | $1.32B | 0.87% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CPRJ | 30.68% | $48.46M | 0.69% |
XBI | 28.79% | $5.33B | 0.35% |
ARKG | 28.30% | $977.87M | 0.75% |
GNOM | 27.44% | $53.29M | 0.5% |
IBB | 27.19% | $5.92B | 0.45% |
EFAA | 26.63% | $100.51M | 0% |
RSPA | 26.35% | $290.25M | 0% |
QQA | 24.87% | $172.66M | 0% |
FBT | 24.21% | $1.08B | 0.56% |
BBH | 23.53% | $368.79M | 0.35% |
DVYE | 22.71% | $740.90M | 0.49% |
CPSJ | 22.63% | $32.78M | 0.69% |
CPNJ | 22.38% | $29.51M | 0.69% |
OVT | 22.23% | $48.62M | 0.8% |
HDRO | 22.11% | $164.26M | 0.3% |
PBE | 22.10% | $233.11M | 0.58% |
BTC | 21.92% | $3.28B | 0.15% |
ESPO | 21.86% | $303.38M | 0.56% |
XRT | 21.33% | $226.26M | 0.35% |
XT | 21.27% | $2.97B | 0.46% |
SeekingAlpha
Moderna stock dips 10% amid FDA resignation, signaling regulatory risks. Strong cash reserves can't offset competitive and mRNA challenges. Learn more on MRNA stock here.
Yahoo
Massive cuts to personnel and funding within the Department of Health and Human Services presents a headache for vaccine approval and development, analysts say.
Yahoo
Biotech stocks were hammered Monday after Peter Marks, a top FDA official, resigned amid a clash with Robert F. Kennedy Jr.
Yahoo
The resignation of one of the FDA's top officials, Peter Marks, is worrying Wall Street as they await a replacement.
Yahoo
Moderna (MRNA) shares dropped nearly 12% following news that FDA official Peter Marks will step down on April 5th, causing uncertainty in the biotech sector, particularly for vaccine makers. Yahoo Finance Senior Reporter Anjalee Khemlani joins Morning Brief to discuss how this leadership change could impact companies like Moderna, Novavax (NVAX), and others in the healthcare industry. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.
Yahoo
Shares in Moderna and Novavax fell Monday, following a Wall Street Journal report that the Food and Drug Administration’s top vaccine official has been pushed out. Shares in some larger drugmakers, such as GSK, also retreated.